Boehringer Inhalers
Links shared publicly online about this topic
Pfizer-Boehringer’s Spiriva Mist Inhaler May Raise Death Risk, Review Says - Bloomberg
bloomberg.com — “Boehringer Ingelheim GmbH and Pfizer Inc. ’s Spiriva mist inhaler for chronic lung disease may raise the risk of an early death, a review of five studies found.” View full resource at bloomberg.com
Most Recently Shared on June 15, 2011 at 7:41 am By:
Boehringer, Pfizer’s Spiriva May Raise Death Risk, Study Finds: Boehringer Ingelheim GmbH and Pfizer Inc. (PFE... http://bloom.bg/lTgFqo
Boehringer unit to exit contract manufacturing - FiercePharma
fiercepharma.com — “A Boehringer Ingeheim drug plant is exiting the contract manufacturing business. Ben Venue Laboratories, which makes injectable and inhaled drugs, plans to bail out of contract work over the next Read more...” View full resource at fiercepharma.com
Most Recently Shared on August 22, 2011 at 8:20 pm By:
Boehringer's BVL unit to segue out of contract manufacturing...after trouble supplying Pfizer's scarce Doxil drug. http://t.co/suAHlCp
Combivent Respimat Inhalation Spray Approved for COPD - MPR
empr.com — “Boehringer Ingelheim announced that the FDA has approved Combivent Respimat (ipratropium bromide and albuterol), a propellant-free metered dose inhalation spray that uses a slow-moving mist, for the treatment of chronic obstructive pulmonary disease (COPD).” View full resource at empr.com
Most Recently Shared on October 10, 2011 at 3:15 pm By:
Combivent Respimat Inhalation Spray Approved for #COPD http://ow.ly/6SDtO
FDA finds no heart risk with Spiriva inhaler - More health news- msnbc.com
msnbc.msn.com — “Federal health regulators say recent data do not show a connection between a popular respiratory inhaler and previously reported risks of stroke, heart attack and death.” View full resource at msnbc.msn.com
Most Recently Shared on January 14, 2010 at 9:45 pm By:
msnbc.com - Health Health News
FDA finds no heart risk with Spiriva inhaler http://bit.ly/4Cdqb5
FDA Approves Combivent® Respimat® (ipratropium Bromide And Albuterol) Inhalation Spray For The Treatment Of Patients With COPD
medicalnewstoday.com — “Boehringer Ingelheim Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved COMBIVENT RESPIMAT, a new, propellant-free inhaler product that uses a slow-movin” View full resource at medicalnewstoday.com
Most Recently Shared on October 8, 2011 at 8:15 am By:
MedicalNewsToday: FDA Approves Combivent® Respimat® (ipratropium Bromide And Albuterol): http://t.co/ge6Qqfb1 Full http://t.co/Df7AzTG5
Data released early to show lung drug Spiriva safe | Reuters
reuters.com — “LONDON (Reuters) - Results of a clinical study to be presented next month show the blockbuster inhaled lung drug Spiriva, marketed by Pfizer and Boehringer Ingelheim, actually cuts heart risk, researchers” View full resource at reuters.com
Most Recently Shared on September 24, 2008 at 4:05 pm By:
Interesting development on Spiriva risk. 6k-pt study from PFE & BI shows no heart risk. http://tinyurl.com/4dnwcl
FDA Approves Spiriva HandiHaler for the Reduction of COPD Exacerbations
drugs.com — “Spiriva HandiHaler (tiotropium bromide) is used for the reduction of exacerbations in patients with chronic obstructive pulmonary disease (COPD). Includes Spiriva HandiHaler side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on December 20, 2009 at 7:35 pm By:
FDA Approves Spiriva HandiHaler for the Reduction of COPD Exacerbations - http://bit.ly/8NzjMW
Pfizer's Spiriva enhances asthma treatment
health.yahoo.net — “Adding Spiriva to conventional therapy improves symptoms in patients whose asthma is poorly controlled and gives them more days without breathing problems, researchers reported on Sunday.” View full resource at health.yahoo.net
Most Recently Shared on September 19, 2010 at 7:40 pm By:
Pfizer's Spiriva enhances asthma treatment http://bit.ly/bjbbUa
Press Release Archive
us.boehringer-ingelheim.com — “Press Release Archive” View full resource at us.boehringer-ingelheim.com
Most Recently Shared on October 8, 2011 at 2:57 pm By:
Boehringer Ingelheim announces #FDA approval of #COPD medication in new propellant-free inhalerhttp://tinyurl.com/3puy94f
Spiriva HandiHaler approved for the reduction of COPD exacerbations - MPR
empr.com — “Spiriva HandiHaler (tiotropium powder for oral inhalation, from Boehringer Ingelheim and Pfizer) has been approved by the FDA for the reduction of exacerbations in patients with chronic obstructive pulmonary disease (COPD).” View full resource at empr.com
Most Recently Shared on December 21, 2009 at 4:59 pm By:
MPR News: Spiriva HandiHaler approved for the reduction of COPD exacerbations: Spiriva HandiHaler (tiotropium powde... http://bit.ly/6ritCw
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Lungs and Breathing
Organizing lung and breathing resources shared by health experts, advocates, and organizations into WisdomCards.
-
FiercePharma
FiercePharma's 140. Join 50,000 pharma insiders on our free newsletter at FiercePharma.com
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
Advertisement
